AMN Healthcare Q1 revenue falls 16% to $690 million; posts $1 million net loss
AMN Healthcare reported first-quarter 2025 revenue of $690 million, down 16% from a year earlier, and a net loss of $1 million, or $0.03 per diluted share, compared with net income of $17 million, or $0.45 per share, in the first quarter of 2024. Adjusted diluted EPS fell to $0.45 from $0.97, and second-quarter revenue guidance of $645 million to $660 million points to a further decline of 11% to 13% from the prior year, which weighs on the outlook for shareholders.
Key points
- Q1 2025 revenue was $690 million, down 16% year over year and 6% sequentially; gross margin was 28.7%, down 270 basis points year over year.
- Net loss was $1 million, or ($0.03) per diluted share, versus net income of $17 million, or $0.45 per share, in Q1 2024.
- Second-quarter 2025 revenue guidance is $645 million to $660 million, 11% to 13% lower than the prior year.
- Cash flow from operations was $93 million in the first quarter, and the company reduced debt by $60 million.
The filing
Written by AI on Nov 8, 2026, 6:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 08, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.